Abcam PLC operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Abcam PLC with three other
pharmaceutical manufacturers in Europe:
sales of 396.00 million Euro [US$439.03 million]
Dottikon ES Holding AG
(147.71 million Swiss Francs [US$152.59 million]
of which 100%
was The pharmaceutical), and
based in Latvia
(137.72 million Euro [US$152.68 million]
Abcam PLC reported sales of £259.90 million (US$341.52 million)
June of 2019.
increase of 11.4%
versus 2018, when the company's sales were £233.20 million.
Sales at Abcam PLC have increased during each of the previous five years
(and since 2014, sales have increased a total of 103%).